Legato Capital Management’s Cardinal Health CAH Stock Holding History

Legato Capital Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,616	Closed	-$341K	–	711
2026 Q1	$341K	Buy	+1,616	New	+$348K	0.03%	608

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Legato Capital Management's CAH Position: Q2 2026 in Review

Legato Capital Management sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,616 shares — an estimated $341K sold.

Legato Capital Management first reported a position in CAH in Q1 2026 and held it in 1 quarter. The position peaked at $341K in Q1 2026. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Legato Capital Management reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Legato Capital Management sold 1,616 Cardinal Health shares in Q2 2026, an estimated $341K.
Legato Capital Management first reported a position in Cardinal Health in Q1 2026 and held it in 1 quarter.
Legato Capital Management's Cardinal Health position peaked at $341K in Q1 2026.
1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.